Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Dis… (NCT02990793) | Clinical Trial Compass
CompletedNot Applicable
Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder
United States158 participantsStarted 2022-04-04
Plain-language summary
The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Willing and able to consent to participate in the study
. Age 18 - 65 years
. Diagnosis of PTSD according to DSM-V criteria via CAPS-5
. Onset of symptoms meeting the DSM-5 criteria for PTSD symptoms persisting for a minimum of 6 months prior to the Screening Visit
. Minimum PCL-5 score of 30
Exclusion criteria
. Index trauma occurred before the age of 16 years
. History of open skull injury
. History of a neurological disorder including, but not limited to:
. History of cerebrovascular accident
. History of cerebral aneurysm
. EEG abnormalities that indicate risk of seizure, i.e., abnormal focal or general slowing, or ictal spikes, during the EEG recording
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested something called MeRT — which I understand combines EEG brain mapping with personalized magnetic stimulation — can you explain how that works and whether it might be relevant to my situation given that I have PTSD?
2Since this trial is listed as Phase NA and has already been completed, what do the results actually show about whether MeRT changed PTSD symptoms, and are those results strong enough to inform my care?
3The trial also enrolled people with traumatic brain injury and postconcussive symptoms alongside PTSD — does that overlap matter for someone like me, and does it affect how the findings might apply?
4Given that this trial is now completed, is MeRT something that's available outside of a research setting, or would I still need to seek out a specialized clinic, and what would that look like practically?
5Before considering something like MeRT, would it make sense for me to try established PTSD treatments first — like trauma-focused therapy or approved medications — and how would you weigh those options against a newer approach like this one?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.